POL6014

Neutrophil elastase inhibitor

Phase of research

Phase One Clinical Trial

How it helps

Anti-Inflammatory

General information

N/A

Synonyms

N/A

Marketed as

N/A

Dietary sources

N/A

Structure image not available

N/A

Drug-Mutation Relation

Treats

Mutation Number of sources Average impact factor
General effect
1 4.29
Link Tested on Impact factor Notes
Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis. humans 4.29

Does not treat

Mutation Number of sources Average impact factor